Skip to content

JBA TEAM: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

JBA TEAM

BE 0674.408.138
NACE 86.910, Medical imaging and medical laboratories
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€1,420
2024 · -€2,740+€4,160
Equity
€37,027
2024 · €35,607+€1,420
Cash
€23
2024 · €4,686-€4,663
Balance sheet total
€37,489
2024 · €36,316+€1,174

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€5,837

    up €5,837 (+18.5%), from €31,629 to €37,466

  • Cash -€4,663

    down €4,663 (-99.5%), from €4,686 to €23

    mainly Receivables within one year (-€5,837) and Trade debts (-€133)

Equity and liabilities
  • Reserves +€1,420

    up €1,420 (+4.4%), from €32,607 to €34,027

    of which Distributable reserves: +€1,420

Income statement
  • Gross operating margin +€4,186

    up €4,186, from -€2,568 to €1,618

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€2,740
Gross operating margin +€4,186
Other operating items -€14
Financial charges -€12
Result 2025 €1,420

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€4,663
Investment €0
Financing €0
Cash 2024 €4,686
Net result for the year +€1,420
Receivables within one year -€5,837
Trade debts -€133
Tax, wage and social debts -€113
Cash 2025 €23
Every line side by side 26 lines
Line Code 2024 2025 Change %
Total assets 20/58 €36,316 €37,489 +€1,174 +3.2%
Current assets 29/58 €36,316 €37,489 +€1,174 +3.2%
Amounts receivable within one year 40/41 €31,629 €37,466 +€5,837 +18.5%
Other amounts receivable 41 €31,629 €37,466 +€5,837 +18.5%
Cash at bank and in hand 54/58 €4,686 €23 -€4,663 -99.5%
Total equity and liabilities 10/49 €36,316 €37,489 +€1,174 +3.2%
Equity 10/15 €35,607 €37,027 +€1,420 +4.0%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €32,607 €34,027 +€1,420 +4.4%
Non-distributable reserves 130/1 €12,620 €12,620 = 0.0%
Reserves not available under the articles 1311 €12,620 €12,620 = 0.0%
Distributable reserves 133 €19,987 €21,407 +€1,420 +7.1%
Amounts payable 17/49 €709 €462 -€246 -34.8%
Amounts payable within one year 42/48 €709 €462 -€246 -34.8%
Trade debts 44 €596 €462 -€133 -22.4%
Suppliers 440/4 €596 €462 -€133 -22.4%
Taxes, remuneration and social security 45 €113 - -€113
Taxes 450/3 €113 - -€113
Non-recurring operating charges 66A - €14 +€14
Gross operating margin 9900 -€2,568 €1,618 +€4,186
Operating profit (loss) 9901 -€2,568 €1,604 +€4,172
Financial charges 65/66B €172 €184 +€12 +7.1%
Recurring financial charges 65 €172 €184 +€12 +7.1%
Profit (loss) for the period before taxes 9903 -€2,740 €1,420 +€4,160
Profit (loss) for the period 9904 -€2,740 €1,420 +€4,160
Profit (loss) for the period to be appropriated 9905 -€2,740 €1,420 +€4,160

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.